Frailty, not age alone, shapes recovery after stroke, editorial argues

Stroke remains the second leading cause of death and the primary driver of adult disability worldwide, and the burden of cerebrovascular disease is shifting profoundly as populations age. An editorial published in Frontiers in Neurology on 23 October 2026 argues that this demographic shift makes one biological variable more urgent than chronological age itself: frailty. Written by Piergiorgio Lochner of the University of the Saarland, Simona Lattanzi of Marche Polytechnic University, Andrea Morotti of the University of Brescia, and Marialuisa Zedde of Azienda Unita Sanitaria Locale IRCCS di Reggio Emilia, the editorial introduces a Research Topic in the journal’s Stroke section that gathers clinical cohort data, biomarker discovery, and machine learning models on elderly and frail stroke patients.

The authors frame the problem in stark terms. Older age is a known risk factor for stroke, and both advanced age and frailty are critical determinants of worse functional outcome, institutionalization, and mortality following an ischemic or haemorrhagic event. As admissions for stroke in older people accelerate, the editorial contends that defining the factors that govern response to treatment, particularly acute reperfusion therapies such as intravenous thrombolysis and endovascular thrombectomy, has become an urgent clinical need. Despite landmark advances in acute stroke therapy, current evidence-based stroke protocols remain inadequately validated in the oldest-old patients and in frail ones, and age itself has an impact on frailty risk.

Central to the argument is the claim that chronological age alone offers poor resolution for clinical decision-making. Instead, the editorial highlights frailty as a biological, neurocognitive, and social syndrome characterized by diminished physiological reserve, heightened vulnerability to stress, and multisystem dysregulation, a construct that has emerged as a key mediator of clinical recovery. Frailty extends beyond chronological age, directly influencing post-stroke survival, the functional recovery trajectory, and quality of life across the spectrum of cerebrovascular events. Yet the interaction between premorbid multidimensional frailty, baseline blood-based markers, advanced radiomic profiles, and response to acute revascularisation strategies remains unexplored in everyday practice, according to the authors.

Measuring frailty is not straightforward. The editorial notes that frailty can be assessed with different scales, each with its own advantages and disadvantages depending on the cohort of application. This measurement question matters because understanding the clinical impact of frailty is essential to optimize resource allocation, refine acute treatment algorithms, and build tailored post-stroke rehabilitation strategies. The Research Topic brings together multi-center insights, novel biomarker discovery, machine learning models in radiomics, and clinical cohort data across pivotal studies to advance prognostic modeling in elderly and frail stroke patients, and it also addresses pre-existing cognitive impairment, or PreCI, and vulnerability in acute stroke care.

Pre-existing cognitive impairment, the editorial explains, frequently co-exists with physical frailty and vascular comorbidities, resulting in a complex clinical profile that might influence hyperacute decision-making and long-term recovery. The authors place this in the context of global epidemiological trends: even though age-standardized death rates and disability-adjusted life year rates declined over the past 30 years, absolute stroke deaths and disability-adjusted life years continuously rose due to rapid population aging and metabolic disease expansion. They also offer a possible speculation, explicitly labeled as such, that PreCI correlates with greater baseline stroke severity, higher rates of acute complications, lower functional recovery, reduced survival, and a significantly higher rate of permanent institutionalization.

Among the biomarkers examined in the Research Topic, sarcopenia receives particular attention. Evaluating two retrospective cohorts, one with 152 ischemic stroke patients undergoing endovascular thrombectomy and the other comprising 322 patients with spontaneous intracerebral hemorrhage, two studies demonstrated a consistent pattern regarding temporalis muscle thickness, a cranial measure of muscle loss. While TMT-assessed sarcopenia initially correlated with poorer functional outcomes, reflected in higher modified Rankin Scale scores, and higher mortality in unadjusted analyses across both groups, it lost statistical significance following multivariable adjustment. The editorial suggests these congruent results indicate that while cranial muscle thinning highlights a vulnerable patient phenotype, TMT-assessed sarcopenia may function primarily as a marker of advanced age and comorbidity burden rather than an independent driver of post-stroke disability.

Cognitive recovery also features prominently in the collected findings. In one study, baseline frailty evaluated through a 32-item Frailty Index was not associated with 6-month cognitive recovery; instead, male sex, higher baseline Montreal Cognitive Assessment scores, and thalamic lesions were identified as independent predictors of favorable cognitive recovery. Another study focused on post-stroke dysphagia, which independently drives poor outcomes in the oldest-old patients, highlighting the critical value of frailty screening during hyperacute care planning. Nutritional and inflammatory markers add further prognostic texture: an elevated admission C-reactive protein/albumin ratio independently predicted higher mortality in elderly patients with post-stroke dysphagia, though serum albumin alone offered comparable prognostic utility.

Multivariable models can provide prognostic information in elderly stroke patients in other domains as well. Five independent risk factors were identified to predict pressure injuries during stroke recovery: hemorrhagic stroke subtype, advanced age, hypoalbuminemia, elevated leukocyte count, and low activities of daily living scores. Social frailty was significantly tied to activities of daily living, depression, social support, language impairment, and stroke recurrence, and the editorial argues that improving these patients requires targeted interventions focusing on depression management, ADL rehabilitation, and social support expansion. Additional biomarkers linked to nutritional status, physiological reserves, and inflammation are also discussed: serum iron was reported to exhibit a threshold effect on post-stroke functional recovery, with the suggestion that its correction may be critical for preserving independence in daily activities, and the hemoglobin-to-hematocrit ratio exhibited a non-linear association with 3-month prognosis in acute ischemic stroke, pointing to the potential value of hemorheological balance monitoring for risk stratification.

Looking forward, the editorial sees expectations for artificial intelligence in stroke care, noting for example that machine learning could be helpful to identify those patients who may not benefit from endovascular treatment. The authors conclude that there are currently promising biomarkers and factors associated with the prognosis of frail stroke patients, but that bridging remaining gaps in knowledge requires future research to prioritize inclusive clinical trials, prospective multi-center registries, biomarker validation, and advanced machine learning models evaluating acute effective revascularization response across stratified frailty, cognitive, and radiomic classes. Translating these prognostic insights into dedicated clinical guidelines, they argue, will ensure that therapeutic decisions in older stroke patients are evidence-based, equitable, and aligned with individual functional reserve. The editorial was received on 28 September 2026, accepted on 29 September 2026, and edited and reviewed by Jean-Claude Baron of the University of Cambridge.

Subject of Research: An editorial on frailty as a determinant of stroke outcomes, recovery, and treatment response in aging populations.

Article Title: Editorial: The burden and impact of frailty in stroke

Article References: Lochner, P., Lattanzi, S., Morotti, A., & Zedde, M. (2026). Editorial: The burden and impact of frailty in stroke. Frontiers in Neurology, 17, Article 2012685. https://doi.org/10.3389/fneur.2026.2012685

Image Credits: AI Generated

DOI: 10.3389/fneur.2026.2012685

Keywords: stroke, frailty, aging, endovascular thrombectomy, sarcopenia, temporalis muscle thickness, cognitive impairment, dysphagia, biomarkers, machine learning, rehabilitation, prognosis